First Trust Health Care AlphaDEX Fund Rating $126.20 0.00 (0.00%) Closing price 07/2/2026 04:10 PM EasternExtended Trading$126.16 -0.03 (-0.03%) As of 07/2/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsSEC FilingsShort InterestBuy This Stock First Trust Health Care AlphaDEX Fund Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FXH Aggregate RatingHold 2.41Holdings in FXH have an aggregate rating of Hold based on 456 analyst ratings issued in the past year covering 25 companies (55.8% of the portfolio).FXH Aggregate Price Target$126.20High Prediction$126.20Average Prediction$126.20Low Prediction$126.20Holdings in FXH have an aggregate price target of $126.20 and a range of $126.20 to $126.20 covering 25 companies (55.8% of the portfolio).FXH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold14 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust Health Care AlphaDEX Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 FXH Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.47%HUMHumana$396.38-0.1%2.7109 of 5 stars2.25$293.09 -26.1%28Gap Up3.86%OGNOrganon & Co.$13.57+0.1%2.0833 of 5 stars1.71$11.40 -16.0%72.91%DVADaVita$234.79-0.1%4.098 of 5 stars2.38$199.17 -15.2%8Trending NewsOptions Volume2.85%ELVElevance Health$416.97-0.2%4.7147 of 5 stars2.61$419.16 0.5%23News CoveragePositive NewsAnalyst Forecast2.60%EXELExelixis$55.852.2898 of 5 stars2.35$47.60 -14.8%20Analyst ForecastOptions VolumeGap Down2.52%MOHMolina Healthcare$229.19-0.3%2.5219 of 5 stars2.12$184.81 -19.4%172.48%SOLVSolventum$78.22-0.1%3.1483 of 5 stars2.46$83.73 7.0%132.31%BIIBBiogen$216.123.4703 of 5 stars2.52$217.41 0.6%312.26%CAHCardinal Health$238.79-0.1%3.913 of 5 stars2.83$247.80 3.8%18News CoverageAnalyst Forecast2.25%CICigna Group$287.50-0.1%4.773 of 5 stars2.77$338.30 17.7%22Positive NewsGap Down2.24%INCYIncyte$116.863.9941 of 5 stars2.36$107.85 -7.7%22Options VolumeGap Down2.18%BIOBio-Rad Laboratories$296.780.0%1.055 of 5 stars2.00$303.33 2.2%5News Coverage2.09%ZBHZimmer Biomet$87.50+0.0%4.1947 of 5 stars2.26$102.70 17.4%23Analyst Downgrade1.99%CHEChemed$489.540.0%4.5191 of 5 stars2.33$501.50 2.4%6News CoveragePositive News1.98%GMEDGlobus Medical$80.01-0.1%4.6443 of 5 stars2.87$105.00 31.2%15Positive NewsAnalyst RevisionGap Down1.74%EHCEncompass Health$106.49+0.0%4.9451 of 5 stars2.89$143.86 35.1%9Positive News1.70%HCAHCA Healthcare$409.99-0.1%4.6742 of 5 stars2.58$503.00 22.7%24Analyst ForecastGap Down1.70%IONSIonis Pharmaceuticals$81.803.329 of 5 stars2.90$102.90 25.8%21Insider TradeGap Down1.70%REGNRegeneron Pharmaceuticals$654.274.8574 of 5 stars2.73$792.65 21.2%26Positive NewsAnalyst DowngradeGap Down1.70%UHSUniversal Health Services$157.97-0.2%4.9815 of 5 stars2.28$216.56 37.1%18News CoverageGap Down1.69%ILMNIllumina$188.682.4616 of 5 stars2.32$148.94 -21.1%19Analyst Forecast1.66%PENPenumbra$318.540.0%1.8768 of 5 stars2.11$361.33 13.4%18Negative News1.65%AMGNAmgen$374.153.918 of 5 stars2.43$355.50 -5.0%30Positive NewsAnalyst ForecastGap Down1.63%MRKMerck & Co., Inc.$129.34-0.2%4.4725 of 5 stars2.70$131.83 1.9%20Positive NewsAnalyst ForecastAnalyst RevisionGap Down1.59%QGENQiagen$40.08-0.1%3.3687 of 5 stars2.38$43.15 7.7%13 This page (NYSEARCA:FXH) was last updated on 7/5/2026 by MarketBeat.com Staff. From Our PartnersTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Health Care AlphaDEX Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Health Care AlphaDEX Fund With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.